Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Progen. Co., Ltd.

Clinical trials sponsored by Progen. Co., Ltd., explained in plain language.

Not yet recruiting 1

New diabetes drug enters Head-to-Head test against popular treatment

Disease control Not yet recruiting

This study aims to see if a new injectable drug called PG-102 is safe and effective for controlling blood sugar and weight in people with type 2 diabetes. About 80 participants will be randomly assigned to receive PG-102, a placebo (inactive shot), or an open-label drug called se…

Phase: PHASE2 • Sponsor: ProGen. Co., Ltd. • Aim: Disease control

Last updated Apr 04, 2026 02:05 UTC